News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sciele Pharma, Inc. (SCRX), a Shionogi & Co., Ltd. Company, to Acquire Victory Pharma, Inc., a U.S. Specialty Pharmaceutical Company



5/18/2009 10:59:00 AM

ATLANTA--(BUSINESS WIRE)--Sciele Pharma, Inc. (Head Office: Atlanta, Georgia, USA; CEO and Chairman: Patrick P. Fourteau; hereafter “Sciele”), a U.S.-based group company of Shionogi & Co., Ltd. (Head Office: Osaka; President: Isao Teshirogi; hereafter “Shionogi”) and Victory Pharma, Inc., (Head Office: San Diego, California, USA; President and CEO: Matt Heck; hereafter “Victory”), a privately-held U.S. pharmaceutical company focused on the acquisition, development and marketing of products to treat pain and related conditions, today announced that Sciele has agreed to acquire Victory.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES